000 03407nam a22006255i 4500
001 978-3-030-86076-9
003 DE-He213
005 20250526092116.0
007 cr nn 008mamaa
008 220131s2022 sz | s |||| 0|eng d
020 _a9783030860769
_9978-3-030-86076-9
024 7 _a10.1007/978-3-030-86076-9
_2doi
050 4 _aRC1-1245
050 4 _aRC1-1245
072 7 _aMJ
_2bicssc
072 7 _aMJ
_2bicssc
072 7 _aMED045000
_2bisacsh
072 7 _aMJ
_2thema
072 7 _aMJ
_2thema
082 0 4 _a616
_223
082 0 4 _a616
_223
245 1 0 _aPrevention and Treatment of Atherosclerosis
_h[electronic resource] :
_bImproving State-of-the-Art Management and Search for Novel Targets /
_cedited by Arnold von Eckardstein, Christoph J. Binder.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _aX, 538 p. 40 illus., 37 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aHandbook of Experimental Pharmacology,
_x1865-0325 ;
_v270
505 0 _aDiet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics.
506 0 _aOpen Access
520 _aThis open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. .
650 0 _aInternal medicine.
650 0 _aPharmacology.
650 0 _aDiseases.
650 1 4 _aInternal Medicine.
650 2 4 _aPharmacology.
650 2 4 _aInternal Medicine.
650 2 4 _aDiseases.
700 1 _avon Eckardstein, Arnold.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBinder, Christoph J.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783030860752
776 0 8 _iPrinted edition:
_z9783030860776
776 0 8 _iPrinted edition:
_z9783030860783
830 0 _aHandbook of Experimental Pharmacology,
_x1865-0325 ;
_v270
856 4 0 _uhttps://doi.org/10.1007/978-3-030-86076-9
912 _aZDB-2-SBL
912 _aZDB-2-SXB
912 _aZDB-2-SOB
999 _c74
_d74